References
- CharizanisKLeeKYBatraRMuscleblind-like 2 mediated alternative splicing in the developing brain and dysregulation in myotonic dystrophyNeuron201275343745022884328
- KanadiaRNShinJYuanYReversal of RNA missplicing and myotonia after muscleblind overexpression in a mouse poly (CUG) model for myotonic dystrophyProc Natl Acad Sci U S A200610331117481175316864772
- HaoMAkramiKWeiKMuscleblind-like 2 (Mbnl2)-deficient mice as a model for myotonic dystrophyDev Dyn2008237240341018213585
- WangETCodyNALJogSTranscriptome-wide regulation of pre-RNA splicing and mRNA localization by muscleblind proteinsCell2012150471072422901804
- SuenagaKLeeKYNakamoriMMuscleblind-like 1 knockout mice reveal novel splicing defects in the myotonic dystrophy brainPLoS One201273e3311822509254
- Quera SalvaMABlumenMJacquetteASleep disorders in childhood-onset myotonic dystrophy type 1Neuromuscul Disord2006169–1056457016934465
- GuilleminautCPhilipPRobinsonASleep and neuromuscular disease: bilevel positive airway pressure by nasal mask as a treatment for sleep disordered breathing in patients with neuromuscular diseaseJ Neurol Neurosurg Psychiatry19986522252329703177
- DauvilliersYALabergeLMyotonic dystrophy type 1, daytime sleepiness and REM sleep dysregulationSleep Med Rev201216653954522465566
- YuHLabergeLJaussentIDaytime sleepiness and REM sleep characteristics in myotonic dystrophy: a case-control studySleep201134216517021286250
- LabergeLBeginPDauvilliersYA polysomnographic study of daytime sleepiness in myotonic dystrophy type 1J Neurol Neurosurg Psychiatry20098064264619211594
- Martinez-RodriguezJELinLIranzoADecreased hypocretin-1 (orexin-A) levels in the cerebrospinal fluid of patients with myotonic dystrophy and excessive daytime sleepinessSleep200326328729012749547
- CiafaloniEMignotESansoneVThe hypocretin neurotransmission system in myotonic dystrophy type 1Neurology200870322623018195268
- JohnsMWA new method for measuring daytime sleepiness: the Epworth sleepiness scaleSleep19911465405451798888
- American Academy of Sleep MedicineThe International Classification of Sleep Disorders3rd edDarien, ILAmerican Academy of Sleep Medicine2014
- RechtschaffenAKalesAA Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human SubjectsWashington, DCGovernment Printing Office1968
- NishinoSRipleyBOvereemSHypocretin (orexin) deficiency in human narcolepsyLancet2000355394010615891
- NishinoSRipleyBOvereemSLow cerebrospinal fluid hypocretin (orexin) and altered energy homeostasis in human narcolepsyAnn Neurol200150338138811558795
- KanbayashiTYanoTIshiguroHHypocretin-1 (orexin-A) levels in human lumbar CSF in different age groups: infants to elderly personsSleep200225333733912003164
- MignotELammersGJRipleyBThe role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomniasArch Neurol200259101553156212374492
- RomigiAAlbaneseMLiguoriCSleep-wake cycle and daytime sleepiness in the myotonic dystrophiesJ Neurodegener Dis2013201369202626316996
- HeatwoleCBodeRJohnsonNPatient-reported impact of symptoms in myotonic dystrophy type 1 (PRISM-1)Neurology201279434835722786587
- IwataTSuzukiNMizunoHA marked decrease of orexin in the cerebrospinal fluid in a patient with myotonic dystrophy type 1 showing an excessive daytime sleepinessRinsho Shinkeigaku200949437439 Japanese19715174
- YasuiKSaitoTTatsumiMA case of myotonic dystrophy type 1 with recurrent sleep attack and low CSF orexin levelRinsho Shinkeigaku2010507501 Japanese
- JohanssonACarlströmKAhrénBAbnormal cytokine and adrenocortical hormone regulation in myotonic dystrophyJ Clin Endocrinol Metab2000853169317610999804
- Robson-AnsleyPJde MilanderLCollinsMAcute interleukin-6 administration impairs athletic performance in healthy, trained male runnersCan J Appl Physiol200429441141815317982
- SakaiNCharizanisKLeeKSleep phenotype characterization of muscleblind-like 2 knockout mouse, a central model of myotonic dystrophySleep Abstract Supplement201639A14A15